Gene synthesis could be defined as a flexible and powerful molecule engineering tool employed in synthetic biology which is mainly used for chemical DNA synthesis. Starting from the first artificial gene synthesis by Gobind Khorana's group in 1970, frequent developments and updates have been seen in the synthesis such as sequencing, automation, and amplification. The involvement of various regional and global players in providing commercial gene synthesis services and the usage of gene synthesis technology has revolutionized biology research in recent years. Various researchers are employing these synthetic genes for various life science research domains such as virology, antibody engineering, genetics, neuron sciences, cancer biology, and others. Furthermore, low cost of gene synthesis than the existing processes such as classical cloning and mutagenesis procedures is further augmenting the wider adaption of gene synthesis process across the globe.

The involvement of new players or an increasing number of startups in the market is one of the major driving factors. R&D associated with the gene synthesis and the steadily increasing technological process such as molecular separation technology and protein purification further enables to drive the market swiftly. This results in developing reliable and cost-effective solutions to cater to a wide range of customers across the globe. Due to the several discounts and subsidies provided through federal funding and increasing competitors and emerging players, have resulted in price reduction of the technology. However, technical limitations such as lack of skilled labors are expected to hinder the market growth over the forecast period.

Geographically, North America is expected to be the dominating market for gene synthesis services due to the high demand by the academic institutes and emerging biopharmaceutical companies. Owing to the increasing number of players in the market with their able distribution channel also supports the growth in the region. North America is expected to be followed by Europe owing to the increasing R&D expenditures by the biotech and pharmaceutical companies for better production output. Asia-Pacific is showing the highest growth rate over the globe with China dominating the regional market. The growth of Asia-Pacific is the result of increased investment by government as well as private organization for the growth of synthetic biology and its applications.

Furthermore, the market consists of several market players that are contributing significantly to the market growth. The key players operating in the global gene synthesis market include Thermo Fischer Scientific, Inc., Merck KGaA, GenScript Biotech Corp. Aldevron LLC, and Agilent Technologies Inc. among others. Moreover, the market also consists of some of the new ventures or startup that are influencing the market growth. Biomatik, Custom Array Inc., LC Sciences LLC., Evonetix Ltd. are some of the startups operating in the global gene synthesis market. Optimized LAMP (Loop-mediated Amplification) allowing single copy detection of 35Sp and NOSt in transgenic maize using BART (Bioluminescent Assay in Real Time) has been one of the recent developments in gene synthesis market which is opening new perspective for the market growth.

Research Methodology:

The market study of the global gene synthesis market is incorporated by extensive primary and secondary research conducted by a research team. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market
• Authentic public databases
• Whitepapers, research-papers and news blogs
• Company websites and their product catalog.

The report is intended for biotechnological institutes, government agencies, pharmaceutical companies, and government organizations for overall market analysis and competitive analysis. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Global Gene Synthesis Market Research and Analysis by Method
2. Global Gene Synthesis Market Research and Analysis by End-User

The Report Covers:

• Comprehensive research methodology of the global gene synthesis market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global gene synthesis market.
• Insights about market determinants which are stimulating the global gene synthesis
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of market players.